Biomendi S.A.U.赞助的临床试验
总计224个结果
-
University of AlicantePharmactive Biotech Products S.L.U完全的
-
Universitat de LleidaPharmactive Biotech Products S.L.U招聘中
-
Hipra Scientific, S.L.UVeristat, Inc.; Asphalion; VHIR招聘中
-
Jena University HospitalKKS Netzwerk; iVascular S.L.U.完全的
-
BioMed Valley Discoveries, Inc终止晚期实体瘤 | MAP2K1基因突变 | BRAF基因突变 | MEK突变 | BRAF 基因改变 | 丁酮变更 | MAP2K1 基因改变 | MAP2K2基因突变 | MAP2K2 基因改变美国
-
Orchestra BioMed, IncMedtronic招聘中
-
BioMed Valley Discoveries, Inc完全的
-
Indizen Optical Technologies, S.L.U.Universidad Europea de Madrid招聘中
-
Centre Hospitalier Universitaire de NīmesDedienne Sante S.A.S.终止
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, France完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, France完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, France完全的
-
Asofarma S.A.I. y C.Zenith Technology Corporation Limited完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, France完全的
-
Centre Hospitalier Universitaire de NīmesInvacare Poirier S.A.S.完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, France完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, France完全的多发性硬化症,复发,缓解
-
Matrix Biomed, Inc.MedStar Georgetown尚未招聘
-
Fundació EurecatLaboratorio Echevarne; Health Tech Bio Actives, S.L.U.招聘中
-
iVascular S.L.U.FCRE (Foundation for Cardiovascular Research and Education)招聘中
-
ITF Research Pharma, S.L.U.Spanish Breast Cancer Research Group完全的